The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CD19-targeted chimeric antigen receptor (CAR) T cells in CNS relapsed acute lymphoblastic leukemia (ALL).
 
Haley Newman
No Relationships to Disclose
 
Allison Emily Barz Leahy
No Relationships to Disclose
 
Yimei Li
No Relationships to Disclose
 
Hongyan Liu
No Relationships to Disclose
 
Regina M Myers
No Relationships to Disclose
 
Amanda M DiNofia
No Relationships to Disclose
 
Joseph Gregory Dolan
No Relationships to Disclose
 
Colleen Callahan
Consulting or Advisory Role - Novartis
Speakers' Bureau - Peerview
 
Kaitlin J Devine
Travel, Accommodations, Expenses - Inspire Medical Systems (I)
 
Lisa Wray
No Relationships to Disclose
 
Carl H. June
Stock and Other Ownership Interests - Cabaletta Bio; Carisma Therapeutics; Celldex; Cytosen; Tmunity Therapeutics, Inc.
Honoraria - Johnson & Johnson; Novartis; Pfizer
Consulting or Advisory Role - Cabaletta Bio; Carisma Therapeutics; Celldex; Janssen Oncology; Kiadis Pharma; Viracta Therapeutics; WIRB-Copernicus Group
Research Funding - Novartis; Tmunity Therapeutics, Inc.
Patents, Royalties, Other Intellectual Property - IP licensed to Novartis; Royalties paid to University of Pennsylvania; IP licensed to Tmunity (Inst); Office of Naval Research; IP and patent royalties
 
Stephan A. Grupp
Consulting or Advisory Role - Adaptimmune; Cellular Biomedicine Group; Humanigen; Janssen; Jazz Pharmaceuticals; Novartis; Roche; TCR2 Therapeutics; Vertex
Research Funding - Kite/Gilead; Novartis; SERVIER
 
Susan R. Rheingold
Employment - OptiNose (I)
Stock and Other Ownership Interests - OptiNose (I)
Research Funding - Novartis (Inst); Pfizer (Inst)
 
Shannon L. Maude
Consulting or Advisory Role - Kite, a Gilead company; Novartis
Research Funding - Novartis